venBio Partners

Funding rounds backed by venBio Partners.

Export CSV
Funding disclosed in full
$305M
Median round
$305M
Rounds in calculation
1
1 round
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Parabilis Medicines

Develops medicines targeting historically undruggable protein targets in cancer

$305MSeries FBiotechUnited States
23 participantsAlderline GroupARCH Venture PartnersCatalio Capital ManagementCormorant Asset ManagementFarallon Capital ManagementFidelity Management & Research CompanyForesite CapitalFrazier Life SciencesGeneral CatalystGV (Google Ventures)HBM HealthcareInvusJanus Henderson InvestorsMarshall WaceMilky Way InvestmentsNextech InvestRA Capital ManagementRock Springs CapitalSamsara BioCapitalSixty Degree CapitalSoleus CapitalT. Rowe Price AssociatesvenBio Partners